EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Intermittent theta burst stimulation in adolescents and young adults with depressive disorders: protocol of a randomized, sham-controlled study with a sequential Bayesian design for adaptive trials

Gerrit Burkhardt, Simon E Blackwell, Miaoxi Chen, Lisa Feldmann, Jonas Björklund, Esther Dechantsreiter, Lucia Bulubas, Stephan Goerigk, Daniel Keeser, Peter Falkai, Ellen Greimel, Peter Bechmann und 4 weitere

European Archives of Psychiatry and Clinical Neuroscience · 2025

DOI: 10.1007/s00406-024-01926-5 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift European Archives of Psychiatry and Clinical Neuroscience, 2025. Verfasst von Gerrit Burkhardt und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany. gerrit.burkhardt@med.uni-muenchen.de. Hauptthemen laut MEDLINE: Bipolar Disorder, Major Depressive Disorder, Dorsolateral Prefrontal Cortex, Outcome Assessment, Health Care. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Klinikum der Universität München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intermittent theta burst stimulation (iTBS), a variant of repetitive transcranial magnetic stimulation (rTMS), is an established treatment for adults with major depressive disorder (MDD). Due to its favorable safety profile, iTBS is also a promising early intervention in the transition phase from adolescence to early adulthood, but this has not been systematically investigated to date. Thus, the EARLY-BURST trial investigates the efficacy and safety of iTBS over the left dorsolateral prefrontal cortex (lDLPFC) in treatment-seeking young patients (age 16–26 years) with depressive disorders (i.e. major depressive disorder, persistent depressive disorder, bipolar depression), allowing for relevant co-morbidities. Participants have not received antidepressant or antipsychotic medication during the last 12 months except for short-term (< 2 weeks) on-demand medication. The trial will employ a novel sequential Bayesian, randomized, double-blind, parallel-group, sham-controlled design. Up to 90 patients at two clinical sites (Munich, Augsburg) will be randomized 1:1 to the treatment groups, with sequential analyses starting after 26 patients in each group completed the treatment. The primary outcome will be the difference in depression severity at week 6 (post-treatment visit) between active iTBS and sham iTBS, assessed with the Montgomery-Åsberg Depression Rating Scale (MADRS). The trial is planned to be expanded towards a three-arm leapfrog design, contingent on securing additional funding. Thus, in addition to potentially providing evidence of iTBS’s efficacy in adolescents and young adults with depressive disorders, the EARLY-BURST trial aims at setting the stage for subsequent platform trials in this dynamic research field, where novel adaptive study designs are required to meet the need for rapidly testing promising new vs established rTMS protocols. Trial registration: DRKS00033313.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderMajor Depressive DisorderDorsolateral Prefrontal CortexOutcome Assessment, Health CareTheta RhythmTranscranial Magnetic StimulationAdolescentAdultFemaleHumansMaleYoung AdultBayes TheoremDouble-Blind MethodRandomized Controlled Trials as TopicAdaptive Clinical Trials as Topic

Stichwörter der Autor:innen

Adaptive trial designAdolescentsDepressionMajor depressive disorderTheta burst stimulationTranscranial magnetic stimulation

Autor:innen und Institutionen

  • Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany. gerrit.burkhardt@med.uni-muenchen.de.
  • German Center for Mental Health (DZPG), Partner Site Munich-Augsburg, Munich, Germany. gerrit.burkhardt@med.uni-muenchen.de.
  • Department of Clinical Psychology and Experimental Psychopathology, Institute of Psychology, Georg-August-University of Göttingen, Göttingen, Germany.
  • Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.
  • German Center for Mental Health (DZPG), Partner Site Munich-Augsburg, Munich, Germany.
  • Dept. of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, LMU University Hospital, Munich, Germany.

Förderung

  • Bundesministerium für Bildung und Forschung
  • Klinikum der Universität München

Zitieren

APA

Burkhardt, G., Blackwell, S. E., Chen, M., Feldmann, L., Björklund, J., Dechantsreiter, E., Bulubas, L., Goerigk, S., Keeser, D., Falkai, P., Greimel, E., Bechmann, P., Schulte-Körne, G., Hasan, A., Strube, W., & Padberg, F. (2025). Intermittent theta burst stimulation in adolescents and young adults with depressive disorders: protocol of a randomized, sham-controlled study with a sequential Bayesian design for adaptive trials. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-024-01926-5

Vancouver

Burkhardt G, Blackwell SE, Chen M, Feldmann L, Björklund J, Dechantsreiter E, et al. Intermittent theta burst stimulation in adolescents and young adults with depressive disorders: protocol of a randomized, sham-controlled study with a sequential Bayesian design for adaptive trials. European Archives of Psychiatry and Clinical Neuroscience. 2025. doi:10.1007/s00406-024-01926-5

BibTeX
@article{Burkhardt2025,
  author = {Burkhardt, Gerrit and Blackwell, Simon E and Chen, Miaoxi and Feldmann, Lisa and Björklund, Jonas and Dechantsreiter, Esther and Bulubas, Lucia and Goerigk, Stephan and Keeser, Daniel and Falkai, Peter and Greimel, Ellen and Bechmann, Peter and Schulte-Körne, Gerd and Hasan, Alkomiet and Strube, Wolfgang and Padberg, Frank},
  title = {Intermittent theta burst stimulation in adolescents and young adults with depressive disorders: protocol of a randomized, sham-controlled study with a sequential Bayesian design for adaptive trials},
  journal = {European Archives of Psychiatry and Clinical Neuroscience},
  year = {2025},
  doi = {10.1007/s00406-024-01926-5}
}
Kostenlos starten →